Enzymes as therapeutic agents.
D000721:Ancrod / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001215:Asparaginase / Q000627:therapeutic use; D012103:Batroxobin / Q000627:therapeutic use; D001954:Brinolase / Q000627:therapeutic use; D001963:Bromelains / Q000627:therapeutic use; D002918:Chymotrypsin / Q000627:therapeutic use; D003851:Deoxyribonucleases / Q000627:therapeutic use; D057487:Enzyme Therapy; D004798:Enzymes / Q000494:pharmacology; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use; D008248:Lysostaphin / Q000627:therapeutic use; D003012:Microbial Collagenase / Q000627:therapeutic use; D009113:Muramidase / Q000627:therapeutic use; D010179:Pancreas; D010206:Papain / Q000627:therapeutic use; D013299:Streptodornase and Streptokinase / Q000627:therapeutic use; D013300:Streptokinase / Q000627:therapeutic use; D014020:Tissue Extracts / Q000627:therapeutic use; D014357:Trypsin / Q000627:therapeutic use; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D000970:Antineoplastic Agents; D004798:Enzymes; D005343:Fibrinolytic Agents; D014020:Tissue Extracts; D001963:Bromelains; D013299:Streptodornase and Streptokinase; D003851:Deoxyribonucleases; D009113:Muramidase; D006821:Hyaluronoglucosaminidase; D013300:Streptokinase; D000721:Ancrod; D012103:Batroxobin; D002918:Chymotrypsin; D014357:Trypsin; D014568:Urokinase-Type Plasminogen Activator; D010206:Papain; D003012:Microbial Collagenase; D008248:Lysostaphin; D001954:Brinolase; D001215:Asparaginase